Seeing Is Believing
Currently out of the existing stock ratings of Alex Arfaei, 64 are a BUY (54.24%), 38 are a HOLD (32.2%), 16 are a SELL (13.56%).
Analyst Alex Arfaei, carries an average stock price target met ratio of 86.81% that have a potential upside of 44.45% achieved within 621 days. Previously, Alex Arfaei worked at BMO.
Alex Arfaei’s has documented 236 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ZTS, Zoetis at 09-May-2019.
Analyst best performing recommendations are on KIN (KINDRED BIOSCIENCES).
The best stock recommendation documented was for KIN (KINDRED BIOSCIENCES) at 11/15/2015. The price target of $5 was fulfilled within 1 day with a profit of $0.47 (8.59%) receiving and performance score of 85.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-Jul-2026
$260
$5.51 (2.17%)
$276
3 days ago
(15-Jul-2026)
19/21 (90.48%)
$15.89 (6.51%)
284
Hold Since 07-Jan-2026
$260
$5.51 (2.17%)
$230
5 days ago
(13-Jul-2026)
2/3 (66.67%)
$12 (4.84%)
89
Buy Since 05-Feb-2024
$300
$45.51 (17.88%)
$258
5 days ago
(13-Jul-2026)
16/17 (94.12%)
$52 (20.97%)
318
Buy Since 25-Feb-2026
$280
$25.51 (10.02%)
$260
8 days ago
(10-Jul-2026)
6/7 (85.71%)
$31.92 (12.87%)
161
Buy Since 08-Dec-2021
$295
$40.51 (15.92%)
$260
8 days ago
(10-Jul-2026)
9/10 (90%)
$46.92 (18.91%)
469
What Year was the first public recommendation made by Alex Arfaei?